Medtronic Revenue and Competitors

Fridley, MN USA

Location

$367M

Total Funding

Estimated Revenue & Valuation

  • Medtronic's estimated annual revenue is currently $31.8B per year.(i)
  • Medtronic's estimated revenue per employee is $370,698
  • Medtronic's total funding is $367M.
  • Medtronic's current valuation is $146B. (January 2022)

Employee Data

  • Medtronic has 85784 Employees.(i)
  • Medtronic grew their employee count by 3% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$42310M14061023%N/A$226.6B
#2
$68.5M273N/AN/AN/A
#3
$19670M176108N/AN/A$30.3B
#4
$27.3M109N/AN/AN/A
Add Company

Medtronic, Inc. is a medical technology company that provides lifelong solutions for people with chronic disease. The Company offers therapies to restore patients worldwide to fuller, healthier lives. Medtronic\'s primary products are used for bradycardia pacing, tachyarrhythmia management, atrial fibrillation, heart failure, coronary and peripheral vascular disease, minimally invasive cardiac surgery, heart valve replacement, extracorporeal cardiac support, spinal and neurosurgery,malignant and non-malignant pain, movement disorders, neurodegenerative disorders, and ear, nose and throat (ENT) surgery. Medtronic conducts business through four units: Cardiac Rhythm Management; Vascular; Cardiac Surgery; and Neurological, Spinal and ENT.

keywords:Biotechnology, Medical Devices

$367M

Total Funding

85784

Number of Employees

$31.8B

Revenue (est)

3%

Employee Growth %

$146B

Valuation

N/A

Accelerator

Medtronic News

2022-04-20 - Medtronic PLC stock underperforms Friday when compared to competitors

Shares of Medtronic PLC MDT, -4.68% slid 4.68% to $107.80 Friday, on what proved to be an all-around rough trading session for the stock...

2022-03-30 - Medtronic releases new renal denervation results, closes trial ...

Medtronic (NYSE:MDT) today said its Symplicity Spyral renal denervation (RDN) system demonstrated durable, clinically significant blood...

2022-03-22 - Medtronic completes first patient implants in tibial ...

Fridley, Minnesota-based Medtronic's Titan 2 trial will evaluate the safety and efficacy of the company's implantable tibial neuromodulation (...

2021-10-22 - Medical device leader Medtronic joins race to bring AI to health care

Medtronic, the world’s largest medical device company, is significantly increasing its investments into AI and other technologies, in what it says is an effort to help the health care industry catch up with other industries. While many other industries have embraced technology, health care has ...

2021-09-30 - Medtronic : Expands Minimally Invasive Spine Surgery Ecosystem with Next-Generation Spinal Technologies

DUBLIN, Sept. 30, 2021 /PRNewswire/ -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today announced the latest additions to its minimally invasive spine surgery ecosystem, making it the only company to combine spinal implants, biologics, navigation, robotics, and AI-powere ...